Tissue Factor–Bearing Microparticles and Cancer

ABSTRACT

Blood-borne tissue factor (TF)-bearing microparticles have been shown to play an important role in thrombus propagation in experimental models. The pathophysiologic role of these microparticles is being investigated in several prothrombotic conditions including cancer-associated thrombosis. Tumor cells are known to shed TF-bearing microparticles in vitro, and circulating TF-bearing microparticles can be measured in plasma samples from patients with advanced cancer. We are currently using an impedance-based flow cytometer to accurately size and enumerate TF-bearing microparticles to explore the association between cancer thrombosis and elevations in circulating TF-bearing microparticles.

Cancer thrombosis - microparticles - tissue factor–bearing microparticles

REFERENCES

• 1 Chargaff E, West R. The biological significance of the thromboplastic protein of blood.  J Biol Chem. 1946;  166 189-197
• 2 Wolf P. The nature and significance of platelet products in human plasma.  Br J Haematol. 1967;  13 269-288
• 3 Dvorak H F, Quay S C, Orenstein N S et al.. Tumor shedding and coagulation.  Science. 1981;  212 923-924
• 4 Dvorak H F, Van DeWater L, Bitzer A M et al.. Procoagulant activity associated with plasma membrane vesicles shed by cultured tumor cells.  Cancer Res. 1983;  43 4434-4442
• 5 Martin S J, Reutelingsperger C P, McGahon A J et al.. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl.  J Exp Med. 1995;  182 1545-1556
• 6 Combes V, Simon A C, Grau G E et al.. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant.  J Clin Invest. 1999;  104 93-102
• 7 Mesri M, Altieri D C. Endothelial cell activation by leukocyte microparticles.  J Immunol. 1998;  161 4382-4387
• 8 Zwaal R F, Schroit A J. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells.  Blood. 1997;  89 1121-1132
• 9 Satta N, Toti F, Feugeas O et al.. Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide.  J Immunol. 1994;  153 3245-3255
• 10 Sims P J, Faioni E M, Wiedmer T, Shattil S J. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity.  J Biol Chem. 1988;  263 18205-18212
• 11 Schwager I, Jungi T W. Effect of human recombinant cytokines on the induction of macrophage procoagulant activity.  Blood. 1994;  83 152-160
• 12 Sims P J, Wiedmer T, Esmon C T, Weiss H J, Shattil S J. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity.  J Biol Chem. 1989;  264 17049-17057
• 13 Pei G, Powers D D, Lentz B R. Specific contribution of different phospholipid surfaces to the activation of prothrombin by the fully assembled prothrombinase.  J Biol Chem. 1993;  268 3226-3233
• 14 Gilbert G E, Sims P J, Wiedmer T, Furie B, Furie B C, Shattil S J. Platelet-derived microparticles express high affinity receptors for factor VIII.  J Biol Chem. 1991;  266 17261-17268
• 15 Hoffman M, Monroe D M, Roberts H R. Coagulation factor IXa binding to activated platelets and platelet-derived microparticles: a flow cytometric study.  Thromb Haemost. 1992;  68 74-78
• 16 Giesen P L, Rauch U, Bohrmann B et al.. Blood-borne tissue factor: another view of thrombosis.  Proc Natl Acad Sci U S A. 1999;  96 2311-2315
• 17 Falati S, Gross P, Merrill-Skoloff G, Furie B C, Furie B. Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse.  Nat Med. 2002;  8 1175-1181
• 18 Falati S, Liu Q, Gross P et al.. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin.  J Exp Med. 2003;  197 1585-1598
• 19 Balasubramanian V, Grabowski E, Bini A, Nemerson Y. Platelets, circulating tissue factor, and fibrin colocalize in ex vivo thrombi: real-time fluorescence images of thrombus formation and propagation under defined flow conditions.  Blood. 2002;  100 2787-2792
• 20 Chou J, Mackman N, Merrill-Skoloff G, Pedersen B, Furie B C, Furie B. Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation.  Blood. 2004;  104 3190-3197
• 21 Bastida E, Ordinas A, Escolar G, Jamieson G A. Tissue factor in microvesicles shed from U87MG human glioblastoma cells induces coagulation, platelet aggregation, and thrombogenesis.  Blood. 1984;  64 177-184
• 22 Yu J L, May L, Lhotak V et al.. Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis.  Blood. 2005;  105 1734-1741
• 23 Carr J M, Dvorak A M, Dvorak H F. Circulating membrane vesicles in leukemic blood.  Cancer Res. 1985;  45(11 Pt 2) 5944-5951
• 24 Khorana A A, Ahrendt S A, Ryan C K et al.. Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer.  Clin Cancer Res. 2007;  13 2870-2875
• 25 Nieuwland R, Berckmans R J, McGregor S et al.. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis.  Blood. 2000;  95 930-935
• 26 Nieuwland R, Berckmans R J, Rotteveel-Eijkman R C et al.. Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant.  Circulation. 1997;  96 3534-3541
• 27 Jimenez J J, Jy W, Mauro L M, Horstman L L, Ahn Y S. Elevated endothelial microparticles in thrombotic thrombocytopenic purpura: findings from brain and renal microvascular cell culture and patients with active disease.  Br J Haematol. 2001;  112 81-90
• 28 Shet A S, Aras O, Gupta K et al.. Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes.  Blood. 2003;  102 2678-2683
• 29 Berckmans R J, Neiuwland R, Boing A N, Romijn F P, Hack C E, Sturk A. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation.  Thromb Haemost. 2001;  85 639-646
• 30 Ando M, Iwata A, Ozeki Y, Tsuchiya K, Akiba T, Nihei H. Circulating platelet-derived microparticles with procoagulant activity may be a potential cause of thrombosis in uremic patients.  Kidney Int. 2002;  62 1757-1763
• 31 Mallat Z, Benamer H, Hugel B et al.. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes.  Circulation. 2000;  101 841-843
• 32 Namba M, Tanaka A, Shimada K et al.. Circulating platelet-derived microparticles are associated with atherothrombotic events: a marker for vulnerable blood.  Arterioscler Thromb Vasc Biol. 2007;  27 255-256
• 33 Jy W, Tiede M, Bidot C J et al.. Platelet activation rather than endothelial injury identifies risk of thrombosis in subjects positive for antiphospholipid antibodies.  Thromb Res. 2007;  121 319-325
• 34 Tesselaar M E, Romijn F P, Van Der Linden I K, Prins F A, Bertina R M, Osanto S. Microparticle-associated tissue factor activity: a link between cancer and thrombosis?.  J Thromb Haemost. 2007;  5 520-527
• 35 Hron G, Kollars M, Weber H et al.. Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer.  Thromb Haemost. 2007;  97 119-123
• 36 Zwicker J I, Furie B, Kos C, LaRocca T, Bauer K A, Furie B C. Trousseau's syndrome revisited: tissue factor-bearing microparticles in pancreatic cancer.  Blood. 2005;  106a
• 37 Hercher M, Mueller W, Shapiro H M. Detection and discrimination of individual viruses by flow cytometry.  J Histochem Cytochem. 1979;  27 350-352
• 38 Shapiro H M. Practical Flow Cytometry. 4th ed. New York, NY; Wiley-Liss 2003
• 39 Zwicker J I, Kos C, Johnston K A, Liebman H A, Furie B C, Furie B. Cancer-associated thrombosis: tissue factor-bearing microparticles are associated with increased risk of venous thromboembolic events in cancer patients. Presented at: XX1st Congress of the International Society on Thrombosis and Haemostasis July 6–12, 2007 Geneva, Switzerland;